214 related articles for article (PubMed ID: 33001187)
1. Identifying Optimal Loci for the Molecular Diagnosis of Microsatellite Instability.
Long DR; Waalkes A; Panicker VP; Hause RJ; Salipante SJ
Clin Chem; 2020 Oct; 66(10):1310-1318. PubMed ID: 33001187
[TBL] [Abstract][Full Text] [Related]
2. Accurate Pan-Cancer Molecular Diagnosis of Microsatellite Instability by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing.
Waalkes A; Smith N; Penewit K; Hempelmann J; Konnick EQ; Hause RJ; Pritchard CC; Salipante SJ
Clin Chem; 2018 Jun; 64(6):950-958. PubMed ID: 29632127
[TBL] [Abstract][Full Text] [Related]
3. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
Steeghs EMP; Kroeze LI; Tops BBJ; van Kempen LC; Ter Elst A; Kastner-van Raaij AWM; Hendriks-Cornelissen SJB; Hermsen MJW; Jansen EAM; Nederlof PM; Schuuring E; Ligtenberg MJL; Eijkelenboom A
BMC Cancer; 2020 Apr; 20(1):291. PubMed ID: 32264863
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability detection using a large next-generation sequencing cancer panel across diverse tumour types.
Pang J; Gindin T; Mansukhani M; Fernandes H; Hsiao S
J Clin Pathol; 2020 Feb; 73(2):83-89. PubMed ID: 31530574
[TBL] [Abstract][Full Text] [Related]
6. A molecular portrait of microsatellite instability across multiple cancers.
Cortes-Ciriano I; Lee S; Park WY; Kim TM; Park PJ
Nat Commun; 2017 Jun; 8():15180. PubMed ID: 28585546
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific microsatellite instability: do distinct mechanisms underlie the MSI-L and EMAST phenotypes?
Hile SE; Shabashev S; Eckert KA
Mutat Res; 2013; 743-744():67-77. PubMed ID: 23206442
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer.
Siah SP; Quinn DM; Bennett GD; Casey G; Flower RL; Suthers G; Rudzki Z
Breast Cancer Res Treat; 2000 Mar; 60(2):135-42. PubMed ID: 10845276
[TBL] [Abstract][Full Text] [Related]
9. MSI-XGNN: an explainable GNN computational framework integrating transcription- and methylation-level biomarkers for microsatellite instability detection.
Cao Y; Wang D; Wu J; Yao Z; Shen S; Niu C; Liu Y; Zhang P; Wang Q; Wang J; Li H; Wei X; Wang X; Dong Q
Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37833839
[TBL] [Abstract][Full Text] [Related]
10. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.
Zheng K; Wan H; Zhang J; Shan G; Chai N; Li D; Fang N; Liu L; Zhang J; Du R; Wu Q; Li X; Zhang C
J Transl Med; 2020 May; 18(1):215. PubMed ID: 32466784
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability detection by next generation sequencing.
Salipante SJ; Scroggins SM; Hampel HL; Turner EH; Pritchard CC
Clin Chem; 2014 Sep; 60(9):1192-9. PubMed ID: 24987110
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Microsatellite Instability from Next-Generation Sequencing Data.
Renault V; Tubacher E; How-Kit A
Adv Exp Med Biol; 2022; 1361():75-100. PubMed ID: 35230684
[TBL] [Abstract][Full Text] [Related]
13. Classification and characterization of microsatellite instability across 18 cancer types.
Hause RJ; Pritchard CC; Shendure J; Salipante SJ
Nat Med; 2016 Nov; 22(11):1342-1350. PubMed ID: 27694933
[TBL] [Abstract][Full Text] [Related]
14. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS.
Kautto EA; Bonneville R; Miya J; Yu L; Krook MA; Reeser JW; Roychowdhury S
Oncotarget; 2017 Jan; 8(5):7452-7463. PubMed ID: 27980218
[TBL] [Abstract][Full Text] [Related]
15. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide view of microsatellite instability: old stories of cancer mutations revisited with new sequencing technologies.
Kim TM; Park PJ
Cancer Res; 2014 Nov; 74(22):6377-82. PubMed ID: 25371413
[TBL] [Abstract][Full Text] [Related]
17. Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens.
Akbari MR; Zhang S; Cragun D; Lee JH; Coppola D; McLaughlin J; Risch HA; Rosen B; Shaw P; Sellers TA; Schildkraut J; Narod SA; Pal T
Fam Cancer; 2017 Jul; 16(3):351-355. PubMed ID: 28176205
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability in cancer: a novel landscape for diagnostic and therapeutic approach.
Yamamoto H; Watanabe Y; Maehata T; Imai K; Itoh F
Arch Toxicol; 2020 Oct; 94(10):3349-3357. PubMed ID: 32632538
[TBL] [Abstract][Full Text] [Related]
19. A novel approach for characterizing microsatellite instability in cancer cells.
Lu Y; Soong TD; Elemento O
PLoS One; 2013; 8(5):e63056. PubMed ID: 23671654
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability status is determined by targeted sequencing with MSIcall in 25 cancer types.
Hirotsu Y; Nagakubo Y; Amemiya K; Oyama T; Mochizuki H; Omata M
Clin Chim Acta; 2020 Mar; 502():207-213. PubMed ID: 31730810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
